https://www.selleckchem.com/pr....oducts/nedometinib.h
ncrease HCPs' ability to integrate PROMs into clinical decision-making and to engage patients in their care. The routine use of PROMs in clinical practice may optimize the quality of LBP care and improve patients' outcomes. The proposed multi-component KT intervention is expected to be an effective strategy to increase HCPs' ability to integrate PROMs into clinical decision-making and to engage patients in their care. Tumor mutational burden (TM has both prognostic value in resected non-small cell lung cancer (NSCLC) patients and
إعجاب
علق
شارك
